GSMA
10.9.2019 04:02:10 CEST | Business Wire | Press release
The GSMA today announced the first speakers for the 2019 Mobile 360 Series – Digital Societies conference, which will take place 24-26 September at JW Marriott Hotel Kuala Lumpur, Malaysia. The event is supported by the Malaysian Communications and Multimedia Commission (MCMC) and also the Malaysia Convention and Exhibition Bureau (MyCEB). Host sponsor for the event is Axiata with other event sponsors including Fiberhome (Headline Sponsor), Edotco, Gigabyte, Huawei and Telepin (Industry Sponsors), as well as Arm (eSim Supporting Sponsor).
“We are excited to bring the Mobile 360 – Digital Societies event to Malaysia for the first time as mobile technology is no doubt playing a pivotal role in driving economic development in the Asia Pacific Region,” said, John Hoffman, CEO, GSMA Ltd. “This three-day event will provide a perfect platform for stakeholders to share their experiences and expand the positive impact of mobile throughout this vibrant and diverse region.”
Keynote Speakers
At the event, industry-leading speakers will shine a light on APAC innovation examining how developments in these core areas are powering digital transformation across the region. Speakers confirmed to present at Mobile 360 – Digital Societies include:
- Gobind Singh Deo, Minister of Communication and Multimedia, Malaysia
- YBrs. Encik Al-Ishsal Ishak, Chairman, Malaysian Communications and Multimedia Commission
- Sok Puthyvuth, Secretary of State, Cambodia MPTC
- Tony Fernandes, CEO, AirAsia Group
- Dr Hans Wijayasuriya, Corporate EVP and Regional CEO, South Asia, Axiata
- Loke Hwee Wong, VP, APAC, Boku
- Teddy Oetomo, CSO, Bukalapak
- Michael Patent, CEO, Culture Group
- Albern Murty, CEO, Digi Telecommunications
- Suresh Sidhu, CEO, edotco
- Wang Xiaofei, CMO, Fiberhome
- Louise Easterbrook, CFO, GSMA
- Khoo Yuen Hing, CTO, Huawei
- Masayoshi Sakai, Counsellor, Information-technology Promotion Agency, Japan
- Sohee Shin, SVP, Global Business Unit and Global Alliance Division, KT
- Gokhan Ogut, CEO, Maxis Broadband Sdn Bhd
- Maya Arvini, CCO, Qlue
- Takeshi Fukuizumi, Head of Fintech and Blockchain, Softbank
- Foong Yuh Wen, CEO and Founder, Sushivid
- Anthony Socci, President and General Manager, APAC, Synchronoss
- Vince Kadar, CEO, Telepin
- Brad Jones, CEO, Wave Money
- Kaspar Tiri, Co-Founder, Wolf 3D
- David An, CTO, ZTE Group Asia
The full conference agenda is available at https://www.mobile360series.com/digital-societies/agenda/ .
In addition to the keynotes, a series of in-depth workshops and sessions will allow a deeper dive into the industry’s most complex challenges looking at topics such as Forging Digital Societies Through Digital Platforms , Building Simple, Clear and Fast Public Services and 5G and Digitalisation . Mobile 360 – Digital Societies will examine the attributes that contribute to a successful digital society. Focusing on the digital platforms enabling new and innovative services, the event highlights the key elements that define a successful digital society including citizenship, commerce, identity, lifestyle and connectivity, and how developments in these key areas can lead to gains for society as a whole.
Women4Tech Leaders Reception
Mobile 360 – Digital Societies will host the first Women4Tech Leaders Reception in APAC on 24 September 2019 from 5:30pm-7:30pm. The event will stimulate discussion on the benefits of encouraging gender diversity in the tech industry and addressing what can be done about the current gender gap through education and public policy. It will also look at ways to promote gender diversity culture in business organisations.
Registration for Women4Tech Leaders Reception is available here: www.mobile360series.com/digital-societies/agenda/apply-to-attend-workshop/#contact
Registration for Mobile 360 – Digital Societies is now open; individuals wishing to attend should visit www.mobile360series.com/digital-societies/attend/attendee-registration/ . For further information on Mobile 360 – Digital societies, please visit: www.mobile360series.com/digital-societies/overview/ . Further information on the entire Mobile 360 Series of events is available at www.mobile360series.com/ . Follow developments and updates on Mobile 360 Series (#mobile360) on Twitter @GSMA and on Facebook www.facebook.com/Mobile360Series .
-ENDS-
About the GSMA
The GSMA represents the interests of mobile operators worldwide, uniting more than 750 operators and nearly 400 companies in the broader mobile ecosystem, including handset and device makers, software companies, equipment providers and internet companies, as well as organisations in adjacent industry sectors. The GSMA also produces the industry-leading MWC events held annually in Barcelona, Los Angeles and Shanghai, as well as the Mobile 360 Series of regional conferences.
For more information, please visit the GSMA corporate website at www.gsma.com . Follow the GSMA on Twitter: @GSMA .
View source version on businesswire.com: https://www.businesswire.com/news/home/20190909005062/en/
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Barilla Opens Global Call for Startups Through Good Food Makers 202625.5.2026 11:47:00 CEST | Press release
The program has involved over 1,100 startups across 50+ countries, delivering 26 pilot projects. Barilla Group has opened applications for the 2026 edition of Good Food Makers, its global open innovation program designed to co-develop and test new innovative solutions with startups and innovators inside real industrial environments. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260521973445/en/ Since its launch in 2019, the program has involved more than 1,100 startups from over 50 countries, leading to 26 pilot projects, with over 20 projects currently active thanks to the solutions developed by the program’s alumni. This highlights the program’s role as a concrete platform for industrial scalable innovation. The 2026 edition comes at a pivotal moment for the company, following the launch of BITE (Barilla Innovation & Technology Experience), the new innovation center dedicated to developing the next generation of food prod
JEOL: Sales Launch of the Laser SEM System “LazEdge”25.5.2026 10:16:00 CEST | Press release
JEOL Ltd. (President & CEO: Izumi Oi) has developed the “LazEdge”, an SEM system equipped with a laser processing system, and begins sales on May 25, 2026. Cross-section preparation instruments such as the focused ion beam system (FIB system), are widely used in science and technology fields across research institutes, universities, and industries. In recent years, demand is increasing for a system that can process large-areas at a high speed, while achieving high-quality of the processed surface. “LazEdge” is an instrument integrating JEOL’s SEM with the laser technology proprietary of Hamamatsu Photonics K.K., and enables laser processing inside the specimen chamber of the electron microscope. This system enables high-quality cross-section specimens produced through high-speed, large-area processing to be transferred seamlessly to subsequent analyses, such as SEM observation, elemental analysis, and crystal orientation analysis, without exposure to the external environment. As a resu
TFG-001, A Novel 3D Neural Microtissue Cell Therapy, Demonstrates Superior Functionality and Reinnervation for Parkinson’s Disease25.5.2026 08:00:00 CEST | Press release
TreeFrog Therapeutics, a regenerative medicine biotech company developing next-generation cell therapies, today announced that it will present new preclinical data on TFG-001 at the 7th World Parkinson’s Conference. TFG-001, a 3D neural microtissue cell therapy, demonstrated rapid dopamine release and extensive graft-derived reinnervation across multiple advanced translational Parkinson’s disease models—supporting its potential as a best-in-class candidate. The critical need for reinnervation in Parkinson's disease In Parkinson's disease, an estimated 60–80% of dopaminergic neurons are already lost before motor symptoms even appear. The nigrostriatal pathway degenerates, destroying the essential wiring that connects dopamine-producing neurons to movement control. While chemical dopamine replacements (like levodopa) can manage symptoms, they cannot restore the spatial precision, feedback loops, or dynamic regulation of a healthy brain network. To achieve true functional restoration, it
Galderma Receives U.S. FDA Approval for Differin® Epiduo® Acne Gel Prescription-to-OTC Switch22.5.2026 18:25:00 CEST | Press release
A unique Prescription-to-OTC switch in acne care, this approval expands access to a dermatologist-trusted, prescription-strength treatment for millions of acne sufferers ages 12 years and older Backed by more than 15 years of real-world dermatologist use and a robust clinical research program, this milestone demonstrates the depth of science behind the Differin® and Epiduo® heritage Adapalene plus benzoyl peroxide (0.1/2.5%) was the first FDA-approved, stable, fixed- dose prescription acne treatment to combine of benzoyl peroxide with a retinoid, and is now available over-the-counter The formulation is engineered to target multiple causes of acne more effectively than either of its individual active ingredients alone Galderma (SIX: GALD), the pure-play dermatology category leader, today announced that the United States (U.S.) Food and Drug Administration (FDA) has approved Differin® Epiduo® Acne Gel (Adapalene 0.1% and Benzoyl Peroxide 2.5% Acne Treatment) for over-the-counter (OTC) us
Avanzanite Bioscience’s Partner Agios Announces PYRUKYND® (mitapivat) Approval in the European Union for Adults with Thalassaemia22.5.2026 16:18:00 CEST | Press release
Avanzanite will commercialise and distribute PYRUKYND in Europe under its exclusive agreement with Agios Avanzanite is committed to collaborating with local authorities in the EU to enable access to PYRUKYND for adult patients with thalassaemia Avanzanite Bioscience B.V., a rapidly growing commercial-stage European specialty pharmaceutical company focused on rare diseases, today reported that its partner, Agios Pharmaceuticals, Inc. (Nasdaq: AGIO), a commercial-stage biopharmaceutical company headquartered in Cambridge, Massachusetts focused on delivering innovative medicines for patients with rare diseases, announced that the European Commission has granted marketing authorisation for PYRUKYND® (mitapivat), an oral pyruvate kinase (PK) activator, in adults for the treatment of anaemia associated with transfusion-dependent and non-transfusion-dependent alpha- or beta-thalassaemia, with an orphan medicinal product designation. This press release features multimedia. View the full releas
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom